EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 115 filers reported holding EPIZYME INC in Q3 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,875,000 | -27.6% | 2,500,000 | +651.5% | 0.01% | -45.0% |
Q3 2020 | $3,969,000 | +121.4% | 332,673 | +198.0% | 0.02% | +66.7% |
Q2 2020 | $1,793,000 | -80.6% | 111,620 | -84.8% | 0.01% | -75.0% |
Q2 2019 | $9,237,000 | -32.5% | 735,988 | -33.4% | 0.05% | -22.6% |
Q1 2019 | $13,688,000 | +92.9% | 1,104,800 | +65.1% | 0.06% | +113.8% |
Q3 2018 | $7,095,000 | +181.5% | 669,300 | +259.8% | 0.03% | +190.0% |
Q2 2018 | $2,520,000 | -81.1% | 186,000 | -75.2% | 0.01% | -82.1% |
Q1 2018 | $13,313,000 | +784.0% | 750,000 | +525.0% | 0.06% | +700.0% |
Q4 2017 | $1,506,000 | -91.4% | 120,000 | -87.0% | 0.01% | -91.1% |
Q3 2017 | $17,591,000 | +52.0% | 923,400 | +91.5% | 0.08% | -1.2% |
Q2 2015 | $11,570,000 | -26.7% | 482,100 | -42.6% | 0.08% | -25.9% |
Q1 2015 | $15,779,000 | +276.2% | 840,200 | +443.0% | 0.11% | +237.5% |
Q3 2014 | $4,194,000 | – | 154,721 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |